Tandem Diabetes Care's Q2 2025 shows U.S. weakness, margin pressure, and rising competition, raising strategy concerns. See ...

The global interventional radiology products market is witnessing significant growth, driven by factors such as the rising prevalence of chronic diseases, rapid urbanization, and technological ...

The global external defibrillator market is poised for significant growth, driven by factors such as the rising prevalence of sudden cardiac arrest (SCA), increased public awareness, and advancements ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Penumbra today and set a price target of $266.00. The company’s shares closed yesterday at $254.21. Elevate Your ...